Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
- Resource Type
- Article
- Authors
- Xu, Jianming ; Shen, Lin; Zhou, Zhiwei; Li, Jie; Bai, Chunmei; Chi, Yihebali; Li, Zhiping; Xu, Nong; Li, Enxiao; Liu, Tianshu; Bai, Yuxian; Yuan, Ying; Li, Xingya; Wang, Xiuwen; Chen, Jia; Ying, Jieer; Yu, Xianjun; Qin, Shukui; Yuan, Xianglin; Zhang, Tao; Deng, Yanhong; Xiu, Dianrong; Cheng, Ying; Tao, Min; Jia, Ru; Wang, Wei; Li, Jing; Fan, Songhua; Peng, Mengye; Su, Weiguo
- Source
- In The Lancet Oncology November 2020 21(11):1500-1512
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045